PCD Connectathon&Showcase 2013-09-10 Webex

From IHE Wiki
Jump to navigation Jump to search

PCD Connectathon & Showcase Meeting 2013-2014 Cycle

Action Items

You can find the Action Items at PCD-Connectathon&Showcase-ActionItemsCycle8-2013-2014

Agenda

You can find the agenda at http://wiki.ihe.net/index.php?title=PCD_Connectathon%26Showcase_WG_2013-14

Participants

Shantanu Chawla (CareFusion), Ashley Cushens (iSirona), Sue-fen Cuti (Careeverywhere), Bikram Day (Capsule), Paul Elletson (Smiths Medical), Kurt Elliason (Smiths Medical), Al Engelbert (Protolink), John Garguilo (NIST), Bob Gold (Philips), Tom Kowalczyk (Baxter), Monroe Pattillo (Practical Health Interoperability), Paul Sherman (Sherman Engineering), Rob Wilder (Amcomsoft), Manny Furst

Discussion

Item3 Topic Discussion
1 Introductions & Agenda Review
- Manny
Status/Discussion:
No changes were made to the agenda.
Discussion Summary from last meetings were unnecessary: Changes Were Incorporated / Will Be Incorporated in ACM

Decisions/Issues:

Action(s):

2 Meeting Review
- Manny
Status/Discussion:

We had a helpful meeting today. Following discussion members are asked to review

- The updated PIV tests. There are questions about these, the most important:
o Tab PIV 01: Do the four components address the various ways your pump is designed and are they appropriately written? To do this please consider if there are drugs in the table or that need to be added to make it possible for your pump to be tested in each of the four components. If your pump doesn’t support all components you will be able to skip those that don’t. I will be helpful to reply to this email indicating which component(s) is not supported.
o Tab PIV 02: Only minor changes are suggested.
o Tab PIV 03: Do we test the interruption of communication between the gateway and the IOP and/or between the pump and the gateway? Both? How do we make the test steps more understandable?
- Drug Table
o Discussion raised several questions but inconclusive with the recommendation that Jeff and others with pharmaceutical knowledge are needed to determine:
which data is required for the various pump types, what the column titles should be, and whether including the calculated values as reference for the monitors.

The updated spreadsheets were distributed. We will use this Google Group and next Tuesday’s meeting to resolve any questions and define the tests for inclusion in Gazelle.

Decisions/Issues:

Action(s):

3 Announcements
- Manny
Status/Discussion:
- Commercially Available Table
- IPEC Updated and Distributed for Comments
- DEC POI and WCM, IDCO Schedule TBD
- ACM, PIV and IPEC will not be offered as available for Supportive Testing. Paul Sherman will be considering whether DEC should be available for Supportive Testing. Feel free to comment.

Decisions/Issues: Action(s):

4 Next Meetings
- Manny
Status/Discussion:

PIV and Drug Table discussion continued next Tuesday.

Decisions/Issues:

Action(s):

Return to main WG page which has links to individual meeting pages

Return to main PCD Connectathon/Showcase WG page: PCD_Connectathon&Showcase_WG_2013-14

PCD Home